|
GENUV (former, Shine Biopharma) attended "National Assembly Bio-Economy Forum" and the exerpt translation of the relevant article is as below.
National Assembly Bio-Economy Forum “Korea, To Grow into a Global Top Pharmaceutical Power”
Sung-Ho Han, CEO of Shine Biopharma, pointed out that “It takes 5 to 6 years to discover drug candidates for new drug antibody platform, venture capital firms are interested in the projects that can achieve results within 3 years” and “because, unlike the United States, there is no government system in Korea that supports the mid to long-term innovative projects, each company has to raise money by itself to fund such projects.”
To view the original article in Korean, please click here.
|
